Showing results (261-270 of 564) with videos related to

Sort By:
Pageof 57
JAMA|June 3, 2024
The Integration of Clinical Trials With the Practice of Medicine: Repairing a House DividedDerek C Angus, Alison J Huang, Roger J Lewis, et al.
JAMA|June 24, 2010
Infection rate and acute organ dysfunction risk as explanations for racial differences in severe sepsisFlorian B Mayr, Sachin Yende, Walter T Linde-Zwirble, et al.
Plos One|April 8, 2014
Geographic access to high capability severe acute respiratory failure centers in the United StatesDavid J Wallace, Derek C Angus, Christopher W Seymour, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|June 5, 2009
Bile high-mobility group box 1 contributes to gut barrier dysfunction in experimental endotoxemiaRunkuan Yang, Keita Miki, Niku Oksala, et al.
The Journal of Infectious Diseases|November 1, 2003
Protective efficacy of CAP18106-138-immunoglobulin G in sepsisH Shaw Warren, Robina Matyal, Jennifer E Allaire, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|April 12, 2002
Liposomal NAD(+) prevents diminished O(2) consumption by immunostimulated Caco-2 cellsAbrar U Khan, Russell L Delude, Yong Y Han, et al.
Journal of Cardiothoracic and Vascular Anesthesia|October 7, 2008
A phase II multicenter double-blind placebo-controlled study of ethyl pyruvate in high-risk patients undergoing cardiac surgery with cardiopulmonary bypassElliott Bennett-Guerrero, Madhav Swaminathan, Alina M Grigore, et al.
Shock (Augusta, Ga.)|October 25, 2008
Beneficial effects of ethyl pyruvate in a mouse model of spinal cord injuryTiziana Genovese, Emanuela Esposito, Emanuela Mazzon, et al.
Radiation Research|November 2, 2007
Ethyl pyruvate, a potentially effective mitigator of damage after total-body irradiationMichael Epperly, Shunqian Jin, Suhua Nie, et al.
Pageof 57